article thumbnail

STAT+: Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access

STAT News

Supreme Court to review a controversy over so-called skinny labels for medicines, arguing that an appeals court finding threatens the availability of lower-cost generic drugs. For instance, a generic drug could be marketed to treat one type of heart problem, but not another.

article thumbnail

United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com

BioTech 365

United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue reading (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis to consider sale or separation of Sandoz business

Bio Pharma Dive

The generic drug unit has struggled in recent years, while Novartis has moved to focus more narrowly on higher-margin branded medicines.

article thumbnail

Cost of brand-name epilepsy drugs increased by 277% over eight years

Scienmag

MINNEAPOLIS – The cost of brand-name drugs for epilepsy increased by 277% from 2010 to 2018, according to a study published in the June 15, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.The cost of generic drugs for epilepsy decreased by 42% over the same period.

article thumbnail

Faster FDA Approvals Don’t Affect Generic Drug Availability or Cost

Pharmacy Checkers

I’m proud to share that PharmacyChecker has published a white paper that examines prices and availability of newly approved generic drugs. Our report, based on 40 generic medications that were approved from 2017-2018, clearly shows that generic drug approvals often don’t lead to greater affordability or even access here in the U.S.

article thumbnail

Top 60 U.S. Brand Name Drug Prices are 75% Lower Internationally, According to Rand Corporation Study

Pharmacy Checkers

The Rand Corporation has released an impressive study showing that brand name drugs cost far more in the United States than in other countries – on average 344% more. For those of you looking for a methodologically strong analysis of international drug prices and a history of related studies, this is the report for you.

article thumbnail

Our Generic Drug Supply Is Sick

NY Times

Competition for market share at rock-bottom prices has led to shortages, price-spikes, allegations of price-fixing, and substandard and even dangerous practices.